Image pharmaphorum Editor Views & Analysis Results gap between digital leaders and laggards Karl Goossens, director of commercial analytics at Veeva Systems Europe, recently spoke with pharmaphorum, discussing how effective omnichannel execution drives revenue and productivity. Views & Analysis It’s time get real with healthcare's commitment to net zero Every fraction of a degree matters Views & Analysis Propelling clinical research into the 21st century Two and a half years ago, Covid-19 began to infect hundreds, then thousands, then millions of people, and was eventually declared a global pandemic. Patients Sponsored Measuring the intangible – what is the true value of a “pati... Load more results
Views & Analysis Results gap between digital leaders and laggards Karl Goossens, director of commercial analytics at Veeva Systems Europe, recently spoke with pharmaphorum, discussing how effective omnichannel execution drives revenue and productivity.
Views & Analysis It’s time get real with healthcare's commitment to net zero Every fraction of a degree matters
Views & Analysis Propelling clinical research into the 21st century Two and a half years ago, Covid-19 began to infect hundreds, then thousands, then millions of people, and was eventually declared a global pandemic.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.